FilingIndex
← The Wire
CGENNasdaq

COMPUGEN LTD

Biological Products, (No Diagnostic Substances) · L3 · CIK 1119774

Compugen Ltd. discovers and develops cancer immunotherapies using its AI/ML platform

$193M
Market cap
$2.16
Last close
+3.4%
1D
+4.3%
5D
257K
Volume
Price · last 39 sessions-18.2%
May 4L $1.96 · H $3.03Jun 29
435
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Mar 26, 2026: 1 sold $24K.

DateInsiderActionSharesPriceValue
Mar 26, 2026Levine ZuritSVP, Business DevelopmentSell11,875$2.04$24K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance